[The significance for prognostic factor of pathological complete response (pCR) after neoadjuvant chemotherapy]

Nihon Rinsho. 2012 Sep:70 Suppl 7:162-5.
[Article in Japanese]
No abstract available

MeSH terms

  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Female
  • Humans
  • Neoadjuvant Therapy*
  • Prognosis
  • Receptor, ErbB-2 / analysis
  • Treatment Outcome

Substances

  • ERBB2 protein, human
  • Receptor, ErbB-2